Koninklijke Philips (NYSE:PHG) Shares Bought by Vanguard Personalized Indexing Management LLC

Vanguard Personalized Indexing Management LLC grew its position in Koninklijke Philips (NYSE:PHG) by 15.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 42,140 shares of the technology company’s stock after purchasing an additional 5,522 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Koninklijke Philips were worth $1,062,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of PHG. Bruce G. Allen Investments LLC raised its stake in Koninklijke Philips by 6.1% in the second quarter. Bruce G. Allen Investments LLC now owns 6,590 shares of the technology company’s stock valued at $166,000 after buying an additional 381 shares in the last quarter. Riverwater Partners LLC raised its position in shares of Koninklijke Philips by 3.4% during the 2nd quarter. Riverwater Partners LLC now owns 16,201 shares of the technology company’s stock worth $408,000 after acquiring an additional 534 shares in the last quarter. Dorsey & Whitney Trust CO LLC lifted its stake in Koninklijke Philips by 5.7% during the fourth quarter. Dorsey & Whitney Trust CO LLC now owns 11,374 shares of the technology company’s stock worth $265,000 after purchasing an additional 615 shares during the last quarter. CWM LLC boosted its holdings in Koninklijke Philips by 21.9% in the second quarter. CWM LLC now owns 3,429 shares of the technology company’s stock valued at $86,000 after purchasing an additional 616 shares in the last quarter. Finally, Legacy Capital Group California Inc. increased its stake in Koninklijke Philips by 4.1% in the second quarter. Legacy Capital Group California Inc. now owns 16,446 shares of the technology company’s stock valued at $414,000 after purchasing an additional 651 shares during the last quarter. 13.67% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Monday, July 15th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold”.

Koninklijke Philips Stock Down 1.4 %

PHG opened at $30.15 on Tuesday. Koninklijke Philips has a one year low of $17.75 and a one year high of $31.50. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.74 and a current ratio of 1.16. The stock has a market capitalization of $28.33 billion, a P/E ratio of -31.40, a price-to-earnings-growth ratio of 1.06 and a beta of 0.73. The business’s 50-day simple moving average is $28.97 and its 200-day simple moving average is $25.84.

Koninklijke Philips (NYSE:PHG) last released its quarterly earnings results on Monday, July 29th. The technology company reported $0.32 EPS for the quarter. The company had revenue of $4.80 billion for the quarter. Koninklijke Philips had a positive return on equity of 10.15% and a negative net margin of 2.35%. Analysts anticipate that Koninklijke Philips will post 1.51 EPS for the current year.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.